Internal Medicine, Pulmonary Disease · Philadelphia, PA
NPI
1831279488
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
219 N Broad St
Philadelphia, PA, 19107
Phone (215) 762-2688
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
1,747 services
Medicare patients, 2024
431
Average age 74
Drug cost, 2024
$9.6M
3,089 prescriptions
Company payments, 2025
$45K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin D Wind was code 99214 (office e&m - established), 281 times for 185 patients. In total Benjamin D Wind billed 1,747 services in 31 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 281 | 185 | $90.44 | $25K |
| 99215 Office E&M - Established | Office | 216 | 119 | $132.33 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 191 | 154 | $12.39 | $2,367 |
| 94729 Pulmonary Function Testing | Office | 181 | 160 | $39.93 | $7,228 |
| 99233 Hospital E&M - Subsequent | Facility | 159 | 87 | $88.20 | $14K |
| 94060 Pulmonary Function Testing | Office | 155 | 142 | $26.88 | $4,166 |
| 94726 Pulmonary Function Testing | Office | 104 | 97 | $40.24 | $4,185 |
| 99291 Critical Care E&M | Facility | 92 | 47 | $159.55 | $15K |
| 94010 Pulmonary Function Testing | Office | 82 | 75 | $20.13 | $1,651 |
| 94727 Pulmonary Function Testing | Office | 73 | 70 | $32.12 | $2,345 |
| 94618 Pulmonary Function Testing | Office | 63 | 47 | $25.72 | $1,621 |
| 99222 Hospital E&M - Initial | Facility | 36 | 35 | $97.67 | $3,516 |
| 99204 Office E&M - New | Office | 33 | 33 | $102.92 | $3,396 |
| 99205 Office E&M - New | Office | 32 | 32 | $156.23 | $4,999 |
By year: 2022 $97K for 1,227 services; 2023 $107K for 1,394 services; 2024 $121K for 1,747 services.
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin D Wind prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 378 prescriptions and refills. In total Benjamin D Wind wrote 3,089 Medicare prescriptions that cost $9.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 378 | 431 | 186 | $13K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 310 | 447 | 77 | $276K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 276 | 460 | 77 | $286K |
| Tadalafil Generic | 161 | 162 | 23 | $175K |
| Tyvaso Dpi Treprostinil | 149 | 149 | 23 | $3.6M |
| Famotidine Generic | 143 | 314 | 57 | $2,951 |
| Opsumit Macitentan | 125 | 125 | 16 | $1.5M |
| Sildenafil Citrate Generic | 119 | 121 | 22 | $52K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 84 | 131 | 25 | $58K |
| Torsemide Generic | 83 | 151 | 26 | $1,418 |
| Azithromycin Generic | 80 | 95 | 19 | $1,069 |
| Prednisone Generic | 71 | 130 | 36 | $436 |
| Montelukast Sodium Generic | 68 | 171 | 23 | $456 |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 66 | 74 | 32 | $3,672 |
| Roflumilast Generic | 48 | 79 | 14 | $5,308 |
Brand drugs: 1,726 claims; generic drugs: - claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin D Wind $45K ($45K in general payments such as food, travel and fees) from 15 companies. The largest payer was United Therapeutics Corporation with $22K.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 29 | $22K |
| Actelion Pharmaceuticals US, Inc. JNJ | 35 | $21K |
| GlaxoSmithKline, LLC. GSK | 5 | $122 |
| Insmed, Inc. INSM | 5 | $118 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $104 |
| Grifols USA, LLC | 3 | $89.26 |
| Merck Sharp & Dohme LLC MRK | 3 | $66.5 |
| Verona Pharma, Inc. VRNA | 2 | $52.1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49.34 |
| Baxter Healthcare BAX | 1 | $42.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.